KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank33
3Y CAGR-31.6%
5Y CAGR-14.2%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
-31.6%/yr
vs +59.9%/yr prior
5Y CAGR
-14.2%/yr
Recent deceleration
Acceleration
-91.5pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.35 | -45.9% |
| 2024 | 9.90 | -13.7% |
| 2023 | 11.46 | -31.5% |
| 2022 | 16.73 | -38.1% |
| 2021 | 27.04 | +135.3% |
| 2020 | 11.49 | +79.5% |
| 2019 | 6.40 | +150.3% |
| 2018 | 2.56 | -77.5% |
| 2017 | 11.35 | +49.4% |
| 2016 | 7.59 | - |